The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1016/s2214-109x(17)30496-5
|View full text |Cite
|
Sign up to set email alerts
|

Does immunity after Zika virus infection cross-protect against dengue?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
65
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(74 citation statements)
references
References 5 publications
4
65
0
2
Order By: Relevance
“…After the epidemic, herd immunity reduced ZIKV transmission and DENV will re-emerge and potentially infect these DENVnaïve ZIKV-immune sub-populations in The Americas or potentially in other geographic areas newly at risk 26,27 . An epidemiological study based on active Dengue surveillance in Salvador, Brazil, suggests that the reduction of DENV cases after the ZIKV epidemic is due to protection from cross-reactive immune responses between these viruses 28 . Prospective experimental studies are needed to confirm this hypothesis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…After the epidemic, herd immunity reduced ZIKV transmission and DENV will re-emerge and potentially infect these DENVnaïve ZIKV-immune sub-populations in The Americas or potentially in other geographic areas newly at risk 26,27 . An epidemiological study based on active Dengue surveillance in Salvador, Brazil, suggests that the reduction of DENV cases after the ZIKV epidemic is due to protection from cross-reactive immune responses between these viruses 28 . Prospective experimental studies are needed to confirm this hypothesis.…”
Section: Introductionmentioning
confidence: 99%
“…This scenario will more closely resemble the epidemiological setting and time intervals elapsed between the current circulation of related flaviviruses in the Americas. So currently, the role of multiple convalescent periods to ZIKV in the outcome of DENV and other flavivirus infections is in the forefront of discussions based on the limited studies available in experimental models and a lack of characterized human prospective cohorts of this scenario yet 28,[44][45][46] .…”
Section: Introductionmentioning
confidence: 99%
“…Our results demonstrate a significant decline in dengue cases in 2017 in Brazil and Colombia. Studies involving laboratory confirmed cases and enhanced serosurveillance (see for example Ribeiro et al 2018 33 ) will play an important role in pinpointing the mechanism underlying this reduction. Our simulation results show that troughs in dengue incidence are followed by atypically high dengue levels.…”
Section: Stochastic Simulations Incorporating Immune-mediated Interacmentioning
confidence: 99%
“…The unavailability of Zika case count data during the height of the ZIKV epidemic in northeast Brazil, one of the most severely affected regions 33 , may have contributed to our inability to identify a relationship between cumulative Zika cases and observed dengue incidence. In both Brazil and Colombia, misclassified cases (potentially resulting from shared symptoms between case definitions of dengue, Zika, and chikungunya) also may have restricted our ability to detect such a relationship.…”
mentioning
confidence: 99%
“…A previous study suggested that a Zika epidemic would prevent a subsequent dengue epidemic, as a consequence of cross-immunity [31]. Like DENV, ZIKV is a flavivirus, and the structural similarity between them results in cross-immunity.…”
Section: Dengue Chikungunya and Zika Multivariate Clustersmentioning
confidence: 99%